Teradan Clinical Trials | Brandon, FL

Research site

(Unclaimed)

Location

910 Oakfield Drive, Brandon, Florida, United States of America

Site insights

Top conditions

Top treatments

Retatrutide

LY3437943

AD504

Abivertinib Maleate

SUVN-G3031

Ruxolitinib

Atomoxetine

STI-2020

STI-5656

R-oxybutynin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 17 total trials

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age (RSVictory)

The main purposes of Part A of this study are to evaluate the safety, tolerability, and immunogenicity of mRNA-1345 coadministered with a seasonal in...

Active, not recruiting

Respiratory Syncytial Virus

Biological: mRNA-1273.214

Biological: mRNA-1345

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight (TRIUMPH-1)

The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master pr...

Enrolling

Overweight

Knee Pain Chronic

Drug: Retatrutide

Drug: Placebo

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2)

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Enrolling

Overweight

Obesity

Drug: Placebo

Drug: Retatrutide

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

This study assesses the efficacy, safety, and pharmacokinetics of multiple-dose oral administration of daridorexant in pediatric subjects aged 10 to...

Enrolling

Insomnia

Drug: Daridorexant 10 mg

Drug: Daridorexant 25 mg

Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome (V-INCEPTION)

The purpose of this study is to study the effectiveness of implementation of a systematic LDL-C management pathway including treatment with inclisira...

Active, not recruiting

Acute Coronary Syndrome

Drug: Inclisiran

Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obs...

Active, not recruiting

OSA

Drug: Placebo

Drug: AD109

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress

This is a Phase 2 study to assess COVI-MSC in the setting of current standard of care in hospitalized subjects with RT-PCR confirmed SARS-CoV-2 (COVI...

Enrolling

Covid19

Drug: Placebo

Biological: COVI-MSC

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of MK-6552 in participants with Narco...

Enrolling

Narcolepsy

Drug: Placebo

Drug: MK-6552